We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
276
Pliant Therapeutics
PLRX
$65M
$8.2M 0.06%
453,000
+138,000
+44% +$2.1M
PAYC icon
277
Paycom
PAYC
$7.88B
$8.16M 0.06%
39,463
-7,421
-16% -$1.57M
PTCT icon
278
PTC Therapeutics
PTCT
$6.18B
$8.04M 0.06%
291,652
– –
BLK icon
279
Blackrock
BLK
$167B
$7.96M 0.05%
9,800
-358
-4% -$250K
RLAY icon
280
Relay Therapeutics
RLAY
$4B
$7.94M 0.05%
721,070
-250,000
-26% -$2.11M
FOLD
281
DELISTED
Amicus Therapeutics
FOLD
$7.86M 0.05%
553,879
-25,000
-4% -$284K
INDA icon
282
iShares MSCI India ETF
INDA
$6.81B
$7.83M 0.05%
160,370
+10,900
+7% +$496K
KURA icon
283
Kura Oncology
KURA
$793M
$7.79M 0.05%
541,417
-150,005
-22% -$1.48M
RAPT
284
DELISTED
RAPT Therapeutics
RAPT
$7.78M 0.05%
39,158
– –
NLY icon
285
Annaly Capital Management
NLY
$17.3B
$7.76M 0.05%
400,774
+357,260
+821% +$6.37M
PEN icon
286
Penumbra
PEN
$12.6B
$7.69M 0.05%
30,573
-14,319
-32% -$3.17M
DNLI icon
287
Denali Therapeutics
DNLI
$3.79B
$7.68M 0.05%
357,878
– –
BMI icon
288
Badger Meter
BMI
$3.87B
$7.42M 0.05%
48,087
+6,833
+17% +$995K
OPCH icon
289
Option Care Health
OPCH
$3.58B
$7.41M 0.05%
+220,000
New +$6.76M
TSCO icon
290
Tractor Supply
TSCO
$16.3B
$7.33M 0.05%
170,415
-27,910
-14% -$1.14M
URBN icon
291
Urban Outfitters
URBN
$6.46B
$7.28M 0.05%
204,001
-180,631
-47% -$6.29M
DE icon
292
Deere & Co
DE
$165B
$7.24M 0.05%
18,096
-258
-1% -$97.3K
MORF
293
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7.22M 0.05%
249,933
– –
T icon
294
AT&T
T
$164B
$7.16M 0.05%
426,734
-23,456
-5% -$370K
AMT icon
295
American Tower
AMT
$83.5B
$7.12M 0.05%
32,987
+2,135
+7% +$403K
RARE icon
296
Ultragenyx Pharmaceutical
RARE
$2.46B
$7.1M 0.05%
148,480
+99,000
+200% +$3.84M
CERE
297
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$7.09M 0.05%
167,221
-160,000
-49% -$4.6M
KRYS icon
298
Krystal Biotech
KRYS
$10.7B
$6.82M 0.05%
55,000
-15,000
-21% -$1.66M
ACGL icon
299
Arch Capital
ACGL
$35.7B
$6.78M 0.05%
91,244
+26,815
+42% +$2.19M
AXSM icon
300
Axsome Therapeutics
AXSM
$11.7B
$6.77M 0.05%
85,084
+35,000
+70% +$2.34M
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.